Create an account for 10% off your first order
- 🔬 For Research Purposes Only
- Free Shipping on $250+
- 99%+ Purity Guaranteed
Out of stock
$42.95
Research Use Only: Products are intended solely for laboratory research and analytical purposes. Unless explicitly stated otherwise, they are not intended for use in diagnostic procedures, food, drugs, medical devices, cosmetics, or for human or animal consumption.
$42.95
Research Use Only: Products are intended solely for laboratory research and analytical purposes. Unless explicitly stated otherwise, they are not intended for use in diagnostic procedures, food, drugs, medical devices, cosmetics, or for human or animal consumption.
Retatrutide is a 39-residue, lipid-modified peptide specifically designed to activate three class B GPCRs: the GLP-1 receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. Structural work using cryo-EM has shown that retatrutide engages conserved peptide-binding motifs on each receptor while also inducing receptor-specific conformations that support simultaneous triple agonism.
In metabolic research, retatrutide is employed as a tool compound for obesity, diabetes, and NAFLD/NASH models. Phase 2 clinical studies have reported large reductions in body weight and improvements in glycemic control and liver-fat markers, making it a benchmark molecule for exploring multi-receptor incretin pharmacology. Preclinical and translational experiments assess endpoints such as body-weight trajectories, energy expenditure, lipid handling, hepatic fat content, and pancreatic islet function.
Retatrutide – 10mg
(Batch 7438)
Avg. Purity: 99.105%
Avg. Mass: 10.39mg
Result Date: January 16, 2026
Date Added: January 16, 2026
View Lab Results
